Addus Homecare CORP

Addus HomeCare announced robust second quarter 2026 financial results, showcasing an 8.0% increase in net service revenues and a significant rise in net income and adjusted EBITDA.

Addus HomeCare Corporation held its 2026 annual meeting, re-electing directors, ratifying PricewaterhouseCoopers LLP as auditor, and approving executive compensation.

Addus HomeCare Corporation announced robust financial results for the fourth quarter and full year ended December 31, 2025, driven by significant revenue and adjusted EBITDA increases.

Addus HomeCare Corporation reported a 25.0% increase in net service revenues to $362.3 million for Q3 2025, alongside a 31.6% rise in Adjusted EBITDA and the acquisition of Del Cielo Home Care Services.

Addus HomeCare Corporation filed an amendment to its 8-K, providing unaudited pro forma financial statements for its $350.6 million acquisition of Gentiva's personal care business.

Addus HomeCare Corporation announces the appointment of Heather Dixon as President and Chief Operating Officer, effective September 15, 2025, succeeding W. Bradley Bickham who transitions to an advisory role ahead of his planned March 2026 retirement.

Addus HomeCare Corporation announced robust revenue and net income growth for Q3 and the first nine months of 2025, driven by strategic acquisitions and organic expansion, despite rising interest expenses and regulatory uncertainties.

Addus HomeCare Corporation announced robust financial results for Q2 2025, driven by significant revenue growth across its segments and strategic acquisitions, despite rising interest expenses and regulatory uncertainties.

Addus HomeCare Corporation reports a 20.3% increase in net service revenues for Q1 2025, driven by acquisitions and organic growth across its personal care, hospice, and home health segments.

Addus HomeCare Corporation's Q3 2024 results show a 7% increase in net service revenues compared to the same period last year, driven by growth across all segments.

Addus HomeCare Corporation reports a solid second quarter with revenue growth across all segments, fueled by acquisitions and favorable reimbursement rate adjustments.

Addus HomeCare Corporation reported a solid first quarter in 2024, with notable revenue increases across all segments and improved profitability.

Addus HomeCare Corporation filed an amendment to its 2025 annual report to include previously omitted insider trading and compensation recoupment policies.

Addus HomeCare Corporation reported a significant increase in net service revenues and net income for the fiscal year ended December 31, 2025, driven by organic growth and strategic acquisitions across its personal care, hospice, and home health segments.

Addus HomeCare Corporation's 2024 10-K filing reveals significant revenue growth driven by strategic acquisitions and organic expansion across its personal care, hospice, and home health segments.

Addus HomeCare Corporation's 10-K filing for 2023 highlights a year of revenue growth across its personal care, hospice, and home health segments, alongside strategic acquisitions and a focus on managed care partnerships.

Addus HomeCare Corporation director Veronica Hill-Milbourne was granted 1,449 restricted shares of common stock.

Addus HomeCare Corporation director Esteban Lopez was granted 1,449 restricted shares of common stock.

Addus HomeCare Corporation director Jean Rush was granted 1,449 restricted shares of common stock.

Director Susan T. Weaver was granted 1,449 restricted shares of Addus HomeCare Corp common stock.

Director Darin J. Gordon acquired 1,449 restricted shares of Addus HomeCare Corp as part of a non-employee director compensation grant.

Addus HomeCare Corporation director Mark L. First was granted 1,449 restricted shares of common stock.

Addus HomeCare Corporation has filed its definitive proxy statement for the 2026 Annual Meeting of Shareholders to be held on June 10, 2026.

Addus HomeCare Corporation will hold its 2025 Annual Meeting of Shareholders virtually on June 18, 2025, to vote on director elections, auditor ratification, executive compensation, and other business matters.

Addus HomeCare Corporation will hold its 2024 Annual Meeting of Shareholders virtually on June 12, 2024, to vote on director elections, auditor ratification, and executive compensation.

The Vanguard Group filed an amended Schedule 13G, reporting a 0% beneficial ownership in Addus HomeCare Corp following an internal realignment.

Capital Research Global Investors has reported an 8.0% beneficial ownership stake in Addus HomeCare Corp., holding 1,469,752 shares of common stock.

Wasatch Advisors LP has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership in Addus HomeCare Corp as of December 31, 2025.

Capital Research Global Investors reports a 6.0% beneficial ownership stake in Addus HomeCare Corp. common stock.

Wasatch Advisors LP has reported an updated beneficial ownership of 5.1% in Addus HomeCare Corp, holding 929,154 common shares as of June 30, 2025.

Wasatch Advisors LP has filed an amended Schedule 13G, reporting a beneficial ownership of 6.9% of Addus HomeCare Corp's common stock as of March 31, 2025.